|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,187 |
2,187 |
5,168 |
98,220 |
| Total Buy Value |
$38,963 |
$38,963 |
$136,461 |
$2,585,297 |
| Total People Bought |
1 |
1 |
1 |
2 |
| Total Buy Transactions |
1 |
1 |
2 |
4 |
| Total Shares Sold |
100 |
6,000 |
10,991 |
31,616 |
| Total Sell Value |
$1,905 |
$157,493 |
$334,111 |
$1,291,105 |
| Total People Sold |
1 |
2 |
2 |
3 |
| Total Sell Transactions |
1 |
3 |
6 |
11 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Saia John G. |
Chief Legal Officer |
• – – |
2024-04-15 |
4 |
D |
$17.06 |
$64,982 |
D/D |
(3,809) |
25,665 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,569 |
28,366 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
249 |
3,247 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
68 |
7,582 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2024-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
67 |
4,588 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2024-04-01 |
4 |
D |
$20.25 |
$12,575 |
D/D |
(621) |
11,452 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
12,073 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2024-04-01 |
4 |
D |
$20.25 |
$8,100 |
D/D |
(400) |
21,905 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
974 |
22,305 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2024-04-01 |
4 |
D |
$20.25 |
$10,753 |
D/D |
(531) |
15,971 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,929 |
16,502 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2024-04-01 |
4 |
D |
$20.25 |
$11,624 |
D/D |
(574) |
13,755 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,607 |
14,329 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2024-04-01 |
4 |
D |
$20.25 |
$10,672 |
D/D |
(527) |
36,304 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,340 |
36,831 |
|
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2024-03-31 |
4 |
D |
$20.63 |
$93,021 |
D/D |
(4,509) |
2,092,961 |
|
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,461 |
2,097,470 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2024-03-31 |
4 |
D |
$20.63 |
$93,021 |
D/D |
(4,509) |
1,909,297 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,461 |
1,913,806 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
3,239 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2024-03-18 |
4 |
B |
$17.82 |
$38,963 |
D/D |
2,187 |
12,722 |
2.74 |
- |
|
| Tariq Musa |
Director |
– • – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,998 |
2,998 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
D |
$17.74 |
$7,610 |
D/D |
(429) |
12,453 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,233 |
12,882 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
68 |
7,514 |
|
- |
|
671 Records found
|
|
Page 1 of 27 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
